All Companies

ABBV

ABBVIE INC.

Pharmaceutical Preparations

$263.96updated Sep 19, 2026

Congressional trading profile for ABBVIE INC. (ABBV), covering 37 disclosed transactions by 13 lawmakers.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Total Trades

37

Politicians Trading

13

Last Traded

Jun 2, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Ro KhannaDJul 6, 2026Jun 2, 2026Buy$1,001 - $15,000+22.54%
Ro KhannaDJun 9, 2026May 15, 2026Buy$15,001 - $50,000+25.46%
Ro KhannaDJun 9, 2026May 1, 2026Buy$15,001 - $50,000+27.76%
Julia LetlowRJan 13, 2026Apr 28, 2025Buy$1,001 - $15,000+37.24%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Buy$1,001 - $15,000+15.67%
Marjorie Taylor GreeneRAug 15, 2025Aug 4, 2025Buy$1,001 - $15,000+33.86%
Lisa C. McClainRAug 13, 2025Jul 22, 2025Buy$1,001 - $15,000+41.07%
Lisa C. McClainRAug 13, 2025Jun 17, 2025Buy$1,001 - $15,000+42.31%
Josh GottheimerDJun 11, 2025May 22, 2025Buy$1,001 - $15,000+44.60%
Robert BresnahanRJun 9, 2025May 15, 2025Buy$1,001 - $15,000+45.29%
Josh GottheimerDMay 14, 2025Apr 3, 2025Buy$1,001 - $15,000+30.91%
Josh GottheimerDMay 14, 2025Apr 1, 2025Buy$1,001 - $15,000+27.97%
Jared MoskowitzDMay 9, 2025Apr 7, 2025Buy$1,001 - $15,000+41.50%
Marjorie Taylor GreeneRMay 6, 2025May 5, 2025Buy$1,001 - $15,000+34.63%
Robert BresnahanRMar 27, 2025Feb 25, 2025Buy$1,001 - $15,000+29.30%
Marjorie Taylor GreeneRMar 19, 2025Mar 17, 2025Buy$1,001 - $15,000+23.08%
Jefferson ShreveRMar 9, 2025Feb 24, 2025Buy$50,001 - $100,000+29.34%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Buy$1,001 - $15,000+54.05%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Buy$1,001 - $15,000+54.05%